text: Yo, listen up, I got some knowledge to drop,
  Nonalcoholic fatty liver disease won't stop,
  It's the most common liver disease around,
  New treatments needed, that's what I found.
  
  I studied the effects of T3, that's thyroid hormone,
  And GC-1, an agonist, let me show you the zone,
  On rodents with fatty liver and steatohepatitis too,
  Caused by a choline-methionine deficient diet, it's true.
  
  Male Fischer 344 rats, they were my crew,
  Fed that CMD diet and the changes they grew,
  Fatty liver and mild hepatitis, it was clear,
  But when T3 was given, the fatty change disappeared.
  
  Fatty acid oxidation in mitochondria increased,
  Peroxisomal beta-oxidation, that's the beast,
  T3 prevented the fatty change, it was the key,
  No more fat accumulation, that's what I see.
  
  But I didn't stop there, I wanted to know more,
  Can T3 reverse fatty liver to the core?
  Rats ate CMD diet for 10 weeks, feeling the strain,
  Then T3 was coadministered, reversing the pain.
  
  Liver steatosis regressed, no more fat accumulation,
  Lipid peroxidation decreased, that's the revelation,
  Cyclooxygenase-2 expression went down,
  Phospho-STAT3 and phospho-SAPK/JNK, they wore a frown.
  
  And let me tell you 'bout GC-1, it's a champ,
  No side effects on heart rate, no need to revamp,
  It prevented fat accumulation, that's the deal,
  Steatohepatitis got ameliorated, it's real.
  
  So here's the scoop, TR agonists got the power,
  To inhibit and reverse hepatic steatosis, no need to cower,
  Nutritional models can be tackled, that's the conclusion,
  New treatments on the horizon, it's a revolution.